Trahan Jeremy 4

Accession 0001996104-26-000004

CIK 0001729149other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:55 PM ET

Size

14.1 KB

Accession

0001996104-26-000004

AI-generated summary of this filing

Updated Jan 23, 2026

Viemed (VMD) GC Jeremy Trahan Exercises Derivatives, Sells Shares

What Happened

Jeremy Trahan, General Counsel of Viemed Healthcare (VMD), converted/exercised company awards on January 21, 2026. The filing shows conversions of 14,648 and 3,662 derivative units (RSUs/phantom shares) and the vesting/settlement of related awards.
To cover tax obligations and a cash settlement, 4,783 shares were withheld by the issuer (tax withholding) for $7.49/share (total $35,825) and 3,662 shares were delivered back to the issuer for $7.49/share (total $27,428). Combined proceeds (withholding + settlement) are about $63,253.
These were not open-market purchases — they reflect the conversion/vesting of equity-based awards and internal share transfers to the company for taxes/settlement (commonly a cashless or net-share settlement).

Key Details

Transaction date: January 21, 2026; Form 4 filed January 23, 2026.
Reported entries: conversions/exercises of 14,648 and 3,662 derivative units; 4,783 shares withheld for taxes (code F) at $7.49/share = $35,825; 3,662 shares disposed to issuer (code D) at $7.49/share = $27,428.
Per-share value basis: market close price on January 21, 2026 (footnote F3).
Shares owned after the transactions: not specified in the provided excerpt of the filing.
Notable footnotes: F1–F6 indicate these were RSUs and phantom share units (phantom shares are cash-settled equivalents of common stock), tax withholding to satisfy vesting-related tax obligations, and the awards were originally granted Jan 21, 2025 with vesting in three annual installments.
Filing timeliness: appears timely (transaction 1/21/2026; filing 1/23/2026); no late filing indicated.

Context

This activity represents routine settlement of equity compensation rather than an outright open-market sale or purchase. The conversion/vesting of RSUs and cash-settled phantom shares followed by withholding or share surrender to the company is a common cashless/settlement practice to cover taxes and cash obligations.
For retail investors: these transactions confirm the executive received and settled equity awards but do not necessarily signal the insider's buy/sell market sentiment.

Form 4

Period: 2026-01-21

General Counsel

Transactions

Exercise/Conversion
Common Shares
[F1]
2026-01-21+14,648→ 43,440 total
Tax Payment
Common Shares
[F2][F3]
2026-01-21$7.49/sh−4,783$35,825→ 38,657 total
Exercise/Conversion
Common Shares
[F4]
2026-01-21+3,662→ 42,319 total
Disposition to Issuer
Common Shares
[F3]
2026-01-21$7.49/sh−3,662$27,428→ 38,657 total
Exercise/Conversion
Restricted Stock Units
[F1][F5]
2026-01-21−14,648→ 29,296 total
Exp: 2028-01-21→ Common Shares (14,648 underlying)
Exercise/Conversion
Phantom Share Units
[F4][F6]
2026-01-21−3,662→ 7,324 total
Exp: 2028-01-21→ Common Shares (3,662 underlying)

Footnotes (6)

[F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
[F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
[F3]Per share value is based on the market closing price of the common shares for January 21, 2026.
[F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
[F5]Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.
[F6]Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Signature

/s/ Jesse Bergeron, Attorney-in-Fact|2026-01-23

1 file

VIEMED HEALTHCARE, INC.

CIK 0001729149

Entity typeother